NCT06611969

Brief Summary

The main objective of the study is to study the changes in FEV1 with the introduction of the specific inspiratory muscle training programme in the training programme of the popular athletes included. In addition, the secondary aims are to observe the differences in the respiratory capacities of the patients, in the vital signs, VO2 max, respiratory frequency and cardiac variability, as well as to assess the running performance of the participants. Participants will be assigned to one of 2 study groups: IMT group (n=20) or not-IMT group (n=20) The IMT group will perform inspiratory muscle training in conjunction with the conventional marathon training plan. The not-IMT group will follow only the conventional marathon training plan. The study will be conducted over a 12 week period.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 13, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 25, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

September 26, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2025

Completed
Last Updated

March 26, 2025

Status Verified

March 1, 2025

Enrollment Period

4 months

First QC Date

September 13, 2024

Last Update Submit

March 24, 2025

Conditions

Keywords

inspiratory muscle trainingrespiratory functionperformanceexercise

Outcome Measures

Primary Outcomes (1)

  • Expiratory forced volume in first second

    FEV1, in liters/second, assessed by spirometry

    Before starting the intervention and after its completion (12 weeks)

Secondary Outcomes (6)

  • Hearth rate variability

    From the beginning to the end of the programme, recorded on a daily basis.

  • Hearth rate

    From the beginning to the end of the programme, recorded on a daily basis.

  • Respiratory rate

    From the beginning to the end of the programme, recorded on a daily basis.

  • Running performance

    From the beginning to the end of the programme, recorded on a daily basis.

  • Maximal inspiratory pressure

    Before starting the intervention and after its completion (12 weeks)

  • +1 more secondary outcomes

Study Arms (2)

Inspiratory muscle training (IMT) plus conventional training group

EXPERIMENTAL

IMT group will perform inspiratory muscle training in conjunction with the conventional marathon training plan

Procedure: Exercise

Conventional training group (not-IMT) group

ACTIVE COMPARATOR

The not-IMT group will follow only the conventional marathon training plan

Procedure: Exercise

Interventions

ExercisePROCEDURE

The training programme will consist of 5 weekly sessions of aerobic work, strength and mobility, plus specific training of the inspiratory muscles, 3 times a week, at a load between 50 and 80% of the maximum inspiratory pressure of each participant, after re-education of their diaphragmatic ventilation.

Inspiratory muscle training (IMT) plus conventional training group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals willing to follow the 16-week running training plan
  • Possibility of combining aerobic training with inspiratory muscle training
  • Previous half marathon runner

You may not qualify if:

  • \- Exclusive or professional dedication to athletics
  • Previous or current use of respiratory muscle training.
  • Inadequate or health risk physical condition
  • Significant chronic cardiorespiratory diagnoses (e.g. moderate-severe COPD).
  • Neurological, muscular or neuromuscular problems that interfere with the ability to participate in tests and training protocols.
  • Discontinuity in the performance of training.
  • A terminal illness or any other major medical contraindication
  • Lack of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Valencia

Valencia, Spain

Location

MeSH Terms

Conditions

Respiratory AspirationMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Francisco Miguel Martínez Arnau, PhD

    Universitat de Valencia, Spain

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The evaluators are unaware of the assignment at all times. Outcomes assessor will discover group assigment after data analysis.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Physiotherapy

Study Record Dates

First Submitted

September 13, 2024

First Posted

September 25, 2024

Study Start

September 26, 2024

Primary Completion

January 30, 2025

Study Completion

July 30, 2025

Last Updated

March 26, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations